O'Dwyer PJ - Search Results

1

Determinants of cisplatin sensitivity in normal versus spontaneously transformed rat ovarian surface epithelial cells.

Perez RP, Johnson SW, Handel LM, O'Dwyer PJ, Hamilton TC. Perez RP, et al. Gynecol Oncol. 1995 Sep;58(3):312-8. doi: 10.1006/gyno.1995.1236. Gynecol Oncol. 1995. PMID: 7672697

2

Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.

Perez RP, O'Dwyer PJ, Handel LM, Ozols RF, Hamilton TC. Perez RP, et al. Int J Cancer. 1991 May 10;48(2):265-9. doi: 10.1002/ijc.2910480219. Int J Cancer. 1991. PMID: 2019469

3

Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.

Yao KS, Godwin AK, Johnson SW, Ozols RF, O'Dwyer PJ, Hamilton TC. Yao KS, et al. Cancer Res. 1995 Oct 1;55(19):4367-74. Cancer Res. 1995. PMID: 7671249

4

Clinical reversal of drug resistance in ovarian cancer.

Ozols RF, O'Dwyer PJ, Hamilton TC. Ozols RF, et al. Gynecol Oncol. 1993 Oct;51(1):90-6. doi: 10.1006/gyno.1993.1252. Gynecol Oncol. 1993. PMID: 8244181 Review.

5

Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.

O'Dwyer PJ, Perez RP, Yao KS, Godwin AK, Hamilton TC. O'Dwyer PJ, et al. Biochem Pharmacol. 1996 Jul 12;52(1):21-7. doi: 10.1016/0006-2952(96)00131-1. Biochem Pharmacol. 1996. PMID: 8678904

6

Current status of oxaliplatin in colorectal cancer.

O'Dwyer PJ, Johnson SW. O'Dwyer PJ, et al. Semin Oncol. 2003 Jun;30(3 Suppl 6):78-87. doi: 10.1016/s0093-7754(03)00215-x. Semin Oncol. 2003. PMID: 12802798 Review.

7

Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-jun antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotype.

Pan B, Yao KS, Monia BP, Dean NM, McKay RA, Hamilton TC, O'Dwyer PJ. Pan B, et al. Biochem Pharmacol. 2002 May 1;63(9):1699-707. doi: 10.1016/s0006-2952(02)00841-9. Biochem Pharmacol. 2002. PMID: 12007573

8

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. Godwin AK, et al. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3070-4. doi: 10.1073/pnas.89.7.3070. Proc Natl Acad Sci U S A. 1992. PMID: 1348364 Free PMC article.

9

Modulation of glutathione and related enzymes in reversal of resistance to anticancer drugs.

O'Dwyer PJ, Hamilton TC, Yao KS, Tew KD, Ozols RF. O'Dwyer PJ, et al. Hematol Oncol Clin North Am. 1995 Apr;9(2):383-96. Hematol Oncol Clin North Am. 1995. PMID: 7642469 Review.

10

Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.

Yao K, Godwin AK, Ozols RF, Hamilton TC, O'Dwyer PJ. Yao K, et al. Cancer Res. 1993 Aug 15;53(16):3662-6. Cancer Res. 1993. PMID: 8101766 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters